Introduction {#Sec1}
============

5-Methyluridine is a non-natural nucleoside that can be used as an intermediate in the synthesis of thymidine, and in the synthesis of nucleoside analogues AZT and stavudine, both of which are used in highly active antiretroviral treatment of HIV/AIDS patients. As the compound needs to be formed as a single isomer, 5-methyluridine can be synthesised through the transglycosylation of [d]{.smallcaps}-ribose-1-phosphate, using guanosine as a donor, and thymine as receptor (Ge et al. [@CR10]; Medici et al. [@CR25]; Rocchietti et al. [@CR30]). Enzymes provide regio- and stereoselectivity, and hence are an ideal option for nucleoside transglycosylation (Prasad et al. [@CR28]; Utagawa [@CR35]). The hydrolysis reaction for the ribose decoupling reaction can be achieved using purine nucleoside phosphorylase (PNPase; EC 2.4.2.1) (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Phosphorolysis of guanosine by purine nucleoside phosphorylase

However, the reagents guanosine and thymine are relatively insoluble, and are particulate substrates with poor reaction kinetics. The most effective method of solubilising these materials is in hot aqueous solutions. Therefore, it would be preferable to utilise thermostable enzymes to catalyse these reactions. Enzymes that can be used in this transglycosylation reaction include PNPase, thymidine phosphorylase (TPase; EC 2.4.2.4) and uridine phosphorylase (UPase; EC 2.4.2.3) (Bzowska et al. [@CR4]; Pugmire and Ealick [@CR29]). TPase and UPase are functionally both pyrimidine nucleoside phosphorylases (PyNPase; EC 2.4.2.2.), although UPase is closer in sequence identity to PNPase than PyNPase (Lewkowicz and Iribarren [@CR20]). PNPases are divided into two different classes depending on their tertiary and quaternary structures (Bzowska et al. [@CR4]). Type I PNPases tend to be bacterial in origin and, based on sequence and structural information, appear to have a hexameric structure. Type II PNPases tend to be found in eukaryotes and, based on the sequence and structural information, are trimeric in structure (Bzowska et al. [@CR4]; Pugmire and Ealick [@CR29]). Bzowska et al. ([@CR4]) refer to type I PNPases as high molecular mass PNPases, and the type II PNPases as low molecular mass PNPases on the basis of their quaternary structures (Bzowska et al. [@CR4]). In general, prokaryotic PNPases are more amenable to these transglycosylation reactions as they have broader specificity than their mammalian counterparts (Tonon et al. [@CR34]). In addition, thermophiles have been shown to harbour enzymes that exhibit a much greater thermostability. For example, the thermophile *Geobacillus stearothermophilus* (previously *Bacillus stearothermophilus*) has two purine nucleoside phosphorylases which have been characterised (Hori et al. [@CR14], [@CR15]; Saunders et al. [@CR31]) and applied in the synthesis of 5-methyluridine (Hori et al. [@CR16], [@CR17]). However, although these enzymes are thermostable, they have low levels of expression in the wild type. The genes have both been subsequently successfully expressed in *E. coli* at high levels (Hamamoto et al. [@CR11], [@CR12], [@CR13]).

The present work investigated the nucleoside phosphorylases present in the moderately thermophilic and alkaliphilic organism *Bacillus halodurans* Alk36 (Louw et al. [@CR21]; Crampton et al. [@CR6]). This organism was chosen due to its moderately thermophilic nature. It describes the cloning, heterologous expression in *E. coli*, purification, and evaluation of BHPNP1, a purine nucleoside phosphorylase from *B. halodurans* Alk36.

Methods {#Sec2}
=======

Materials {#Sec3}
---------

All restriction enzymes and the T4-DNA ligase were purchased from Fermentas (Lithuania). The Roche high-fidelity PCR mix was used for all polymerase chain reactions. SDS-PAGE markers were purchased from Fermentas.

Bioinformatics {#Sec4}
--------------

Owing to the high level of sequence identity between the genomes of *B. halodurans* Alk36 and *B. halodurans* C-125 the genome sequence of *B. halodurans* C-125 (Takami et al. [@CR33]) (NC_002570), as published in the DNA Data Bank of Japan (<http://gib.genes.nig.ac.jp>), was searched for novel nucleoside phosphorylase gene sequences using the genomic BLAST (basic local alignment search tool; Altschul et al. [@CR1]) located at the NCBI to confirm that no other PNPases or PyNPases were present apart from the annotated ones. Two PNPase and one PyNPase genes were identified. The two PNPases are BH1531 and BH1532, and the PyNPase was designated BH1533. Primers for the amplification of the PNPase gene BH1531 were designed based on the genome sequence. Isolation and characterisation of the gene corresponding to BH1531 from *B. halodurans* strain Alk36 was subsequently performed. This gene was termed BHPNP1.

Genomic DNA isolation {#Sec5}
---------------------

*Bacillus halodurans* Alk36 was grown overnight at 42°C in Luria Broth (LB) pH 8.5 (10 g/L NaCl; 10 g/L tryptone, 5 g/L yeast extract). Genomic DNA was isolated from *B. halodurans* according to the method of Lovett and Keggins ([@CR22]).

Cloning of the *B. halodurans* Alk36 PNPase gene {#Sec6}
------------------------------------------------

The PNPase gene designated BHPNP1 was amplified using the following primers: BH1531F 5′---GGA[CATATG]{.ul}CTTAACGTAACTCAATTG (*Nde*I site, underlined) and BH1531R 5′---GGT[AAGCTT]{.ul}TTACATGTCTTTAACGATTGC (*Hind*III site, underlined). PCR was performed using the high-fidelity polymerase from Roche (Germany). The PCR amplification protocol employed was as follows: a single 10-min hold at 95°C was followed by 25 cycles of 1 min at 95°C, 1 min at 55°C and 1 min at 72°C. A final 10-min incubation at 72°C was followed by a 4°C hold. The size of the amplified product was confirmed on a 0.8% agarose gel and isolated using the Geneclean kit™ (Qbiogene, USA). The PCR product was ligated into pGEM-T Easy (Promega, USA). Restriction digests were performed with *Nde*I and *Hin*dIII to release the BHPNP1 insert.

The BHPNP1 gene was subsequently ligated using T4-DNA ligase (Fermentas) into the pMS470Δ8 expression vector (Balzer et al. [@CR2]) restricted with *Nde*I and *Hind*III. This gave plasmid pMSPNP. This plasmid was transformed into *E. coli* JM109 (DE3) for expression analysis.

DNA sequencing {#Sec7}
--------------

The insert was sequenced at Inqaba Biotechnology (Pretoria, South Africa) using the PCR primers described above. The sequence was compared with the known nucleotide and amino acid sequence of the BH1531 gene from *B. halodurans* C-125 (protein sequence---BAB05250) and has been submitted to GenBank under the accession number GQ390428.

Homology modelling {#Sec8}
------------------

Multiple sequence alignments were performed using ClustalW (Larkin et al. [@CR19]). Homology modelling was performed using Accelrys Discovery Studio 2.0. A trimeric model was based on the bovine structure 1LVU (Bzowska et al. [@CR5]). A second model was based on the monomeric structure 1VFN (Koellner et al. [@CR18]). Bovine PNPase and BHPNP1 have 49% sequence identity and 61% sequence similarity (Table [1](#Tab1){ref-type="table"}).Table 1Comparison of various PNPases to BHPNP1ProteinPercentage of protein identityPercentage of protein similarityPNPase typeAccession number*E. coli* PNP17.033.0IP0ABP8*E. coli* XapA44.061.0IINP_416902*G. stearothermophilus* PNP174.986.2IIP77834Bovine PNP47.161.1IIP55859Human PNP45.258.5IIP00491*B. halodurans* BH153257.175.6IIBAB05251*B. subtilis* PNP69.678.8IIP46354*G. stearothermophilus* PNP218.332.2IP77835

Growth and induction {#Sec9}
--------------------

Recombinant *E. coli* strains were grown in 50 ml LB medium with 100 μg/ml ampicillin, at 37°C with shaking at 200 rpm. Cultures were induced with 0.25 mM IPTG when they had reached an OD~600~ between 0.05 and 0.1. Cultures were subsequently grown at 30°C with shaking at 150 rpm overnight for enzyme expression.

Batch fermentations {#Sec10}
-------------------

A 1.5 l InFors HT batch fermentor (Labfors, Switzerland) containing 1 l of GMO 20 medium was inoculated with a 50 ml inoculum (overnight culture of *E. coli* JM109 \[pMSPNP\] in LB medium). The composition of the GMO 20 medium was as follows: 14.6 g/l K~2~HPO~4~, 2 g/l (NH~4~)~2~SO~4~, 3.6 g/l Na~2~HPO~4~, 2.5 g/l citric acid, 1.2 g/l MgSO~4~, 5 g/l NH~4~NO~3~, and 20 g/l yeast extract. Glucose (17.5 g/l) and trace element solution (5 ml/l) was sterilized separately and added to the fermenters before inoculation. Ampicillin (100 μg/ml) was aseptically added to the flasks containing the glucose and trace element solution. The trace element solution consisted of the following: 0.4 g/l CaCl~2~.2H~2~O, 16.7 g/l FeCl~3~.6H~2~O, 0.15 g/l MnCl~2~.4H~2~O, 0.18 g/l ZnSO~4~.7H~2~O, 0.125 g/l CuCl~2~.2H~2~O. 0.18 g/l CoCl~2~.6H~2~O, and 20.1 g/l Na~2~EDTA. The pH of the fermentations was controlled at pH 7.2 with 33% *m*/*v* NH~4~OH or 20% *m*/*v* H~2~SO~4~. The temperature was controlled at 37°C and the aeration set to 1 *v*/*v*/*min*. The starting agitation was set at 300 rpm and ramped up manually to control the pO~2~ above 30% saturation. PNPase expression was induced at mid-log phase by adding IPTG to a final broth concentration of 0.5 mM. Fermentations were run for a further 4 h after induction.

Preparation of crude extract {#Sec11}
----------------------------

After induction, the bacteria were harvested by centrifugation (15,000*g*, 20 min). The pellet was re-suspended in minimal sterile deionised water, and subjected to a freeze--thaw cycle alternating between +20 and −20°C. Liberated protein was separated by centrifugation (14,000*g*, 10 min) and stored. The pellet was re-suspended in 1 l sterile deionised water and further disrupted using a cell disruptor (2 Plus, Constant Systems, UK) with 1 pass at 40 kpsi. Cellular debris was removed by centrifugation (15,000*g*, 10 min). The resultant protein solution (supernatants from freeze--thaw and cell disruption processes) were concentrated and washed once with sterile deionised water by ultrafiltration using an Amicon (Millipore, USA) stirred cell ultrafiltration unit (30 kDa cut-off polyethersulfone membrane). The final preparation was lyophilised in the presence of 1% maltose and 1% PEG 8000 (Vertis Genesis 25 l). A portion of the lyophilised product, equivalent to 200 ml original fermentation broth, was re-suspended in 20 mM Tris--HCl buffer (pH 7.5) for further purification.

Column chromatography {#Sec12}
---------------------

Anion exchange chromatography of each sample was performed on an AKTA Prime (Amersham Biosciences, UK) using Toyopearl SuperQ650m anion exchange resin (Tosoh BioSep, USA). Protein was first eluted from the column using a salt gradient of between 50 and 500 mM NaCl in 20 mM Tris--HCl pH 7.2, over 400 ml at a flow rate of 4 ml/min. PNPase activity was assayed in all fractions (5 ml fractions collected) and those containing activity were separately pooled and concentrated by ultrafiltration (30 kDa membrane, Millipore USA). This sample was then re-applied to the anion exchange column and eluted over a salt gradient of 150--400 mM NaCl. Active fractions were pooled and concentrated by ultrafiltration as above.

Tertiary conformation {#Sec13}
---------------------

Denatured (5 min, 95°C) and non-denatured preparations of the enzyme were analysed on a 12% SDS-PAGE gel. The gel was overlaid with a 0.5% agarose solution to determine the position of active subunits. The agarose solution contained 10 mM inosine, 0.2 U/ml xanthine oxidase and 10 mM INT (iodonitrotetrazolium violet) in 20 mM sodium phosphate buffer, pH 7.5. Active PNPase is indicated by a red/pink band on the gel due to the cascade action of the PNPase and xanthine oxidase leading to the reduction of INT to its tetrazolium salt. Positions of active and non-active units were then confirmed by staining the gel with Coomassie brilliant blue G-250.

PNPase assay {#Sec14}
------------

A volume (10 μl) of suitably diluted sample was added to 190 μl of 50 mM sodium phosphate buffer containing 0.5 mM inosine and 0.2 U/ml of xanthine oxidase in UV compatible microtitre plates (Thermomix) (Erion et al. [@CR9]). The change in absorbance at 293 nm due to the liberation of uric acid was measured on a Powerwave HT microplate spectrophotometer (Biotek, USA). One unit of PNPase is defined as the amount of enzyme required to liberate 1 μmol of uric acid from inosine, in the presence of an excess of xanthine oxidase, in 1 min. The extinction coefficient (ε) under these conditions was determined to be 7,454 cm^2^/mol.

Physical characteristics {#Sec15}
------------------------

A pH profile was performed using reaction mixtures (1 ml) containing 1 mM guanosine in 50 mM universal buffer (50 mM Tris, 50 mM boric acid, 33 mM citric acid 50 mM Na~2~PO~4~), adjusted to pH values between 3 and 11 with either HCl or NaOH. PNPase (0.025 U) was added to initiate the reaction. After 10 min of incubation at 40°C, the reaction was stopped by the addition of 0.5 ml of a 5 M NaOH solution. Guanosine conversion and guanine formation were analysed by HPLC on a Waters 2690 HPLC (interfaced with Waters Millennium Software) equipped with Waters 996 Photodiode Array Detector at 260 nm and a Phenomenex Synergi 4u Max-RP 80A, 150 × 4.60 mm column at 22°C. The mobile phase was 25 mM ammonium acetate (pH 4.0), at a flow rate of 1.0 ml/min.

The temperature optimum was determined with reaction mixtures (1 ml) containing 1 mM guanosine in 50 mM sodium phosphate buffer, pH 8.0. PNPase (0.025 U) was added to initiate the reaction. After 10 min of incubation at temperatures between 30°C and 90°C, the reaction was stopped by the addition of 0.5 ml of a 5 M NaOH solution. Guanosine conversion and guanine formation were analysed by HPLC as above. For temperature stability, enzyme solutions were incubated at temperatures between 40 and 70°C. Samples were removed and analysed every 30 min for the first 2 h, followed by less frequent sampling for a further 18 h.

Kinetic parameters {#Sec16}
------------------

The kinetic parameters for PNPase were determined for both inosine (standard assay) and guanosine (assay as described for temperature optimum study) as starting substrates. Initial substrate concentrations were varied between 0.05 and 1.0 mM. The reaction was stopped at 1, 2, 3, 4, 6 and 10 min to ensure measurements remained in the linear range. Michaelis--Menten plots and the linear transformations (Lineweaver--Burk, Hanes--Woolf and Eadie--Hofstee) were used to determine kinetic parameters.

Results and discussion {#Sec17}
======================

Sequence analysis and homology modelling {#Sec18}
----------------------------------------

*Bacillus halodurans* is unusual amongst the *Bacilli* that have been completely sequenced so far in that it contains two type II PNPases as opposed to the types I and II PNPases present in other *Bacillus* species (unpublished data). The gene sequence of BHPNP1 was identical to that of BH1531 from *B. halodurans* C-125 except for a silent substitution at nucleotide 519 (C--T), and hence the protein sequence was identical to that expressed by *B. halodurans* C-125. BLAST analysis indicated that the closest related structure deposited in the protein data base (PDB) was that of the bovine PNP (Table [1](#Tab1){ref-type="table"}; Fig. [2](#Fig2){ref-type="fig"}) which is 47% identical to BHPNP1. On the basis of sequence identity, BH1531 is a member of the type II PNPases.Fig. 2Multiple sequence alignment comparing BHPNP1 to other type II PNPases BHPNP1 was aligned with *G. stearothermophilus* PNP1 (P77834) (Hamamoto et al. [@CR12]), bovine PNP (P55859) (Bzowska et al. [@CR3]), human PNP (P00491) (Williams et al. [@CR36]), *B. subtilis* PNP (P46354) (Schuch et al. [@CR32]), the second *B. halodurans* PNP (BH1532, BAB05251) (Takami et al. [@CR33]) and *E. coli* XapA (NP_416902) (Dandanell et al. [@CR7]). The alignment was generated using ClustalW (Larkin et al. [@CR19]; <http://www.ebi.ac.uk/clustalw>). Residues shown to be important in the binding site of bovine and human PNPases are *underlined* (Mao et al. [@CR23], [@CR24]; Montgomery et al. [@CR26]; Narayana et al. [@CR27]). *Dots* (. and :) indicate partial similarity and *asterisks* (\*) indicate a 100% match

BHPNP1 has low levels of identity to type I PNPases, such as *E. coli* PNP and *G.* *stearothermophilus* PNP2 (17 and 18.3% identity, respectively). It has higher levels of identity to type II PNPases. Selected type II PNPases were aligned using ClustalW (Larkin et al. [@CR19]). Amino acids known to be involved in the activity of the bovine and human enzymes (Lewkowicz and Iribarren [@CR20]; Ealick et al. [@CR8]) were generally conserved, with the exception of Tyr^192^, Ser^234^, Met^236^ and Ala^237^ in BHPNP1 and Cys^115^, Tyr^193^, Met^194^, Ile^210^, Asp^236^, Met^237^ and Ala^238^ in BH1532. These were all conservative substitutions with the exception of Met^236^ (BHPNP1), Cys^115^, Met^194^ and Met^237^ (BH1532). The position and orientation of these residues are shown in Fig. [3](#Fig3){ref-type="fig"}. Hence, it is likely that the active site, and overall tertiary structure, of BHPNP1 should resemble the bovine and human PNPases and is, therefore, likely to be a homotrimer. The structure of BHPNP1 was, hence, modelled based on the structure of the bovine PNPase (Fig. [3](#Fig3){ref-type="fig"}). This structure shows the modelled monomer, including a putative substrate, namely hypoxanthine. Residues that are known to be important in structure and function of the mammalian proteins and are conserved in BHPNP1 are indicated in yellow. Residues that are known to be important in structure and function of the mammalian proteins and are not conserved in BHPNP1 are indicated in red.Fig. 3Homology modelled three-dimensional structure of BHPNP1. Homology modelling of the BHPNP1 structure was performed using the bovine structure 1VFN (Koellner et al. [@CR18]) as a template. The monomer was modelled along with the substrate, hypoxanthine

Tertiary conformation {#Sec19}
---------------------

BHPNP1 and *G. stearothermophilus* PNP1 are 74.9% identical. These proteins are likely to have similar structural characteristics. As already mentioned by Hamamoto et al*.* ([@CR13]), the high level of sequence identity between the *G. stearothermophilus* PNP1 and the eukaryotic PNPases strongly suggest structural similarity. This would also apply to the BHPNP1 protein. However, gel filtration analysis of the *G. stearothermophilus* PNP1 gave an apparent molecular weight of 68,000, potentially indicating a dimeric protein (Hori et al. [@CR15]).

To confirm whether BHPNP1 is a trimer, which the sequence data suggests, or a dimer based on information about *G.stearothermophilus* PNP1 an overlay experiment was performed. The stained gel and overlay are shown in Fig. [4](#Fig4){ref-type="fig"}. The experiment indictated that the predominant tertiary confirmation was a dimer. The expected monomeric subunit was visible in both the heat-treated and non-heat-treated samples at approximately 27 kDa. Another dominant band at approximately 50 kDa on the Coomassie stained gel (lane 2, Fig. [4](#Fig4){ref-type="fig"}a) was related to the active band on the overlay (lane 2, Fig. [4](#Fig4){ref-type="fig"}b). Hence, in contrast to the mammalian system, this enzyme appears to be dimeric.Fig. 412% SDS PAGE gel (**a**) and corresponding activity gel overlay (**b**). *M* marker, *lane 1* heat-treated PNPase preparation (95°C, 5 min); *lane 2* non-heat-treated PNPase preparation. *Arrows* indicate the position of the monomer and the dimer

Enzyme expression and purification {#Sec20}
----------------------------------

The productivity of *B. halodurans* Alk36 BHPNP1 heterologously expressed in *E. coli* JM109 (DE3) was 700 U/l/h in shake flasks, but increased to 3,007 U/l/h under the controlled fermentation conditions. PNPase was purified to 42% purity (by density analysis in SDS-PAGE, Fig. [5](#Fig5){ref-type="fig"}) and a specific activity of 30.2 U/mg total protein with a fold purification of 5.0 from the culture broth (Table [2](#Tab2){ref-type="table"}).Fig. 5Denaturing SDS-PAGE gel (12%) showing successive purification steps. Various fractions from a purification of BHPNP were resolved using 12% SDS-PAGE. *Lane 1* protein marker sizes in kilodaltons, *lane 2* crude extract, *lane 3* concentrated sample after anion exchange column 1, *lane 4* final sample after anion exchange column 2Table 2Fold purification table for the purification of recombinant BHPNP1Total unitsSpecific activityPercentage of recovery (%)Fold purificationInitial culture (intracellular)4,8406.93100.001.00Lyophilised crude extract73220.6515.122.97Ion exchange 1 (0--500 mM NaCl gradient)54122.2411.173.73Ion exchange 2 (150--400 mM NaCl gradient)11030.232.274.99

Physical characteristics {#Sec21}
------------------------

PNPase showed a pH optimum of 7.0, retaining 60% activity between pH 5.7 and 7.4 (Fig. [6](#Fig6){ref-type="fig"}). PNPase had optimum activity at 70°C and a broad activity range, retaining 60% activity between 30 and 74°C (Fig. [7](#Fig7){ref-type="fig"}). Although the optimum temperature of PNPase was shown to be 70°C, only 7.2% activity remained after 30 min incubation at this temperature (*t*~1/2~ − 15.2 min). PNPase did, however, show good stability at 60°C (*t*~1/2~ − 20.8 h) and excellent stability at 40°C, with no change in activity over the time period (19 h).Fig. 6pH optimum profiles of BHPNP1. A pH profile was performed using reaction mixtures (1 ml) containing 1 mM guanosine in 50 mM universal buffer (50 mM Tris, 50 mM boric acid, 33 mM citric acid; 50 mM Na~2~PO~4~), adjusted to pH values between 3 and 11 with either HCl or NaOH. PNPase (0.025 U) was added to initiate the reaction. After 10 min of incubation at 40°C, the reaction was stopped by the addition of 0.5 ml of a 5 M NaOH solution. Guanosine conversion and guanine formation were analysed by HPLC at 260 nm. The mobile phase was 25 mM ammonium acetate (pH 4.0), at a flow rate of 1.0 ml/minFig. 7Temperature optimum profile of BHPNP1. The temperature optimum of BHPNP1 was determined with reaction mixtures containing 1 mM guanosine in 50 mM sodium phosphate buffer, pH 8.0. PNPase (0.025 U) was added to initiate the reaction. After 10 min of incubation at temperatures between 30 and 90°C, the reaction was stopped by the addition of 0.5 ml of a 5 M NaOH solution. Guanosine conversion and guanine formation were analysed by HPLC

Kinetic characterisation {#Sec22}
------------------------

Linear transformation of velocity data obtained for varying initial substrate concentrations showed good linear regression fit where inosine was used (*R*^2^ \> 99% for all plots) and adequate fit for guanosine experiments (*R*^2^ \> 94%). From the plots (Lineweaver--Burk, Eadie--Hofstee and Hanes--Woolf), *K*~m~ and *V*~max~ were determined with \<7% deviation in the values calculated from the three plots. Subsequently, the turnover number (*k*~cat~*)* and the specificity constant were calculated. These values are summarised in Table [3](#Tab3){ref-type="table"}.Table 3Physical and kinetic characteristics of BHPNP1Parameter (units)InosineGuanosineSpecific activity (U mg^−1^)30.23ND*K*~m~ (μM)236206*V*~max~ (mol s^−1^)4.76 × 10^−6^2.03 ×10^−9^*k*~cat~ (s^−1^)2.8 × 10^4^1.2 × 10^1^Specificity constant (M^−1^ s^−1^)1.2 × 10^8^5.87 × 10^4^pH Opt7pH range (60%)5.7--8.4Temp Opt (°C)70Temp range (60%) (°C)32--74Temp stability (*t*~1/2~ at 60°C) (h)20.8Temp stability (*t*~1/2~ at 40°C) (h)\>200

The PNP1 from the thermophile *G. stearothermophilus* has been previously expressed and characterised (Hori et al. [@CR14]; Hamamoto et al. [@CR12]). The *G. stearothermophilus* enzyme has a *p*I of 4.7, with an optimal pH range between 7.5 and 11, in contrast to the optimal pH range of BHPNP1 of between 5.7 and 8.4 and a predicted *p*I of 5.1. The *G.* *stearothermophilus* PNPase is more thermostable then BHPNP1 as it is stable at 70°C for greater then 30 h. In contrast, the half life of PNPase BHPNP1 at 60°C is 20 h. *G.* *stearothermophilus* PNPase *K*~m~ for inosine was similar at 0.22 mM, but had a greater affinity for guanosine at *K*~m~ of 0.14 mM.

Conclusions {#Sec23}
===========

The thermostable type II nucleoside phosphorylase from the bacterium *B. halodurans* Alk36 was expressed heterologously in *E. coli*, purified, and functionally characterised. The enzyme was capable of phosphorolysis of guanosine to yield guanine and ribose-1-phosphate, the latter of which may be used in the enzymatic glycosylation of nucleosides.
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BHPNP1

:   *Bacillus halodurans* purine nucleoside phosphorylase 1

[^1]: Communicated by L. Huang.
